E+H has advised PAI Partners on the acquisition of VAMED Group's rehabilitation business from Fresenius. Schoenherr, working with Latham & Watkins, advised the sellers. Reportedly, Willkie Farr & Gallagher, Novacos, Baer & Karrer, KNPZ Rechtsanwaelte, and Havel & Partners advised on the deal as well.
The transaction remains contingent on regulatory approval.
PAI Partners is a private equity firm with approximately EUR 27 billion in assets under management. Since 1994, it has completed over 100 investments in 12 countries and realized more than EUR 24 billion in proceeds from 60 exits.
According to E+H, VAMED’s rehabilitation business operates 67 clinics and care centers across Germany, Austria, Switzerland, the Czech Republic, and the UK, serving more than 100,000 patients annually. "Supported by around 10,000 highly-skilled staff, the unit provides a comprehensive range of inpatient and outpatient rehabilitation services, as well as specialist acute care."
The E+H team included Partners Philipp Schrader, Ulrike Sehrschoen, Steve Jeitler, and Florian Sagmeister, Counsels Titus Kahr, Niklas Nigl, Helena Neuner, and Felix Frommelt, and Associates Franziska Egger, Yvonne Wohlmuth, Alexandra Stadlober, Markus Feneberger, Vincenz Stockert, Gabriela Kaiser, Lorenz Bogensberger, Juliana Haslinger, and Andrea Posch.
The Schoenherr team included Partners Sascha Hoedl, Constantin Benes, Vladimir Cizek, Christoph Haid, Miriam Simsa, Marco Thorbauer, and Teresa Waidmann, Counsels Michal Jendzelovsky, Helena Hangler, and Johannes Stalzer, Attorneys at Law Zurab Simonishvili, Joseph Moser, Gabriel Ebner, Petr Koral, Jiri Marek, Stefanie Orator-Saghy, and Alexander Pabst, and Associates Stefan Dietrich, Markus Fasching, Stefan Holub, and Nikolaus Stepan.
